AMIX — Autonomix Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $4.93m
- -$5.77m
- 18
- 50
- 17
- 18
Annual cashflow statement for Autonomix Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -13.3 | -1.99 | -15.4 |
| Depreciation | |||
| Non-Cash Items | 12.7 | — | 8.62 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.204 | 0.136 | 0.079 |
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -0.387 | -1.85 | -6.65 |
| Capital Expenditures | — | — | -0.019 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | — | — | -0.019 |
| Financing Cash Flow Items | 0.29 | — | -1.3 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 2.43 | 0.675 | 14.4 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.04 | -1.18 | 7.74 |